Hudson Bay Capital Management’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
CS
Hudson Bay Capital Management's CLLS Position: Q4 2022 in Review
Hudson Bay Capital Management sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 74,532 shares — an estimated $171K sold.
Hudson Bay Capital Management first reported a position in CLLS in Q2 2015 and held it in 23 quarters. The position peaked at $6.93M in Q2 2015. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.
- Hudson Bay Capital Management reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
- Hudson Bay Capital Management sold 74,532 Cellectis shares in Q4 2022, an estimated $171K.
- Hudson Bay Capital Management first reported a position in Cellectis in Q2 2015 and held it in 23 quarters.
- Hudson Bay Capital Management's Cellectis position peaked at $6.93M in Q2 2015.
- 40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.
Based on Hudson Bay Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.